Clinical Trial Update: An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of the radiotracer [18F]-ML-10 to detect tumor response to chemotherapy and radiotherapy in non-small …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• [18F]-ML-10 (Fluorine-18 ML-10)

Snippet

Sponsor: Aposense Ltd. | Conditions: Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms | Phase 2 | Status: UNKNOWN